Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia

Chinese Medical Journal

Volumn 122, Issue 10, 2009, Pages 1188-1194

  Luo, Jing Yun ^a,b   Wu, Gui Fu ^a,c   Xiong, Yan ^a   Chen, Guo Wei ^a   Xie, Qiang ^a,c   Yang, Da Ya ^a   He, Xiao Hong ^a   Zhang, Yan ^c   Liu, Dong Hong ^a   Wang, Kui Jian ^a   Ma, Hong ^a,c   Zheng, Zhen Sheng ^a,c   Du, Zhi Min ^a,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU RED CROSS HOSPITAL   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Angiogenesis; Atherosclerosis; Enhanced external counterpulsation; Progenitor cells; Shear stress; Swine

Indexed keywords

BETA1 INTEGRIN; CD34 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; COUNTERPULSATION; HYPERCHOLESTEROLEMIA; LEUKOCYTE COUNT; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STEM CELL MOBILIZATION;

ANIMALS; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CHEMOKINE CXCL12; COUNTERPULSATION; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68249141227     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.10.014     Document Type: Article

References (33)

1. Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41: 1761-1768.
2. Lawson WE, Hui JC, Kennard ED, Kelsey SF, Michaels AD, Soran O. Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation. Clin Cardiol 2006; 29: 69-73.
3. Tao J, Tu C, Yang Z, Zhang Y, Chung XL, Ma H, et al. Enhanced external counterpulsation improves endothelium-dependent vasorelaxation in the carotid arteries of hypercholesterolemic pigs. Int J Cardiol 2006; 112: 269-274.
4. Wu G, Du Z, Hu C, Zheng Z, Zhan C, Ma H, et al. Angiogenic effects of long-term enhanced external counterpulsation in a dog model of myocardial infarction. Am J Physiol Heart Circ Physiol 2006; 290: H248-H254.
5. Barsheshet A, Hod H, Shechter M, Sharabani-Yosef O, Rosenthal E, Barbash IM, et al. The effects of external counter pulsation therapy on circulating endothelial progenitor cells in patients with angina pectoris. Cardiology 2008; 110: 160-166.
6. Covas DT, Piccinato CE, Orellana MD, Siufi JL, Silva WA, Jr., Proto-Siqueira R, et al. Mesenchymal stem cells can be obtained from the human saphena vein. Exp Cell Res 2005; 309: 340-344.
7. Jean-Pierre Lévesque YT, Nilsson SK, Haylock DN, Simmons PJ. Vascular cell adhesion molecular-1(CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cells mobilization by granulocyte colony-stimulating factor. Blood 2001; 98: 1289-1297.
8. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669-1675.
9. Zhang Y, He X, Chen X, Ma H, Liu D, Luo J, et al. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation 2007; 116: 526-534.
10. Loh PH, Cleland JG, Louis AA, Kennard ED, Cook JF, Caplin JL, et al. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol 2008; 31: 159-164.
11. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 2005; 85: 9-23.
12. Haga M, Chen A, Gortler D, Dardik A, Sumpio BE. Shear stress and cyclic strain may suppress apoptosis in endothelial cells by different pathways. Endothelium 2003; 10: 149-157.
13. Yamamoto K, Takahashi T, Asahara T, Ohura N, Sokabe T, Kamiya A, et al. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol 2003; 95: 2081-2088.
14. Chen XL, Grey JY, Thomas S, Qiu FH, Medford RM, Wasserman MA, et al. Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow. Am J Physiol Heart Circ Physiol 2004; 287: H1452-1458.
15. Buchanan JR, Kleinstreuer C, Hyun S, Truskey GA. Hemodynamics simulation and identification of susceptible sites of atherosclerotic lesion formation in a model abdominal aorta. J Biomech 2003; 36: 1185-1196.
16. Laughlin MH, Newcomer SC, Bender SB. Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype. J Appl Physiol 2008; 104: 588-600.
17. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
18. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001; 98: 10344-10349.
19. Tomanek RJ, Zheng W. Role of growth factors in coronary morphogenesis. Tex Heart Inst J 2002; 29: 250-254.
20. Oettgen P. Transcriptional regulation of vascular development. Circ Res 2001; 89: 380-388.
21. Nor JE, Christensen J, Mooney DJ, Polverini PJ. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999; 154: 375-384.
22. Hu CH, Wu GF, Wang XQ, Yang YH, Du ZM, He XH, et al. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin Med J 2006; 119: 1499-1506.
23. Yang JF, Zhou WW, Tang T, Yu JF, Zhou XM, Hu JG. Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats. Natl Med J Chin (Chin) 2006; 86: 1027-1034.
24. Zhang D, Gai L, Fan R, Dong W, Wen Y. Efficacy and safety of therapeutic angiogenesis from direct myocardial administration of an adenoviral vector expressing vascular endothelial growth factor 165. Chin Med J 2002; 115: 643-648.
25. Bjorndahl M, Cao R, Eriksson A, Cao Y. Blockage of VEGF-induced angiogenesis by preventing VEGF secretion. Circ Res 2004; 94: 1443-1450.
26. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 2001; 104: 2012-2017.
27. Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, et al. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Biol Blood Marrow Transplant 2004; 10: 395-404.
28. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, Ibrahim T, et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006; 295: 1003-1010.
29. Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 2005; 39: 363-376.
30. Tang YL, Qian K, Zhang YC, Shen L, Phillips MI. Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment. Regul Pept 2005; 125: 1-8.
31. Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/ endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004; 109: 2454-2461.
32. Yamamoto K, Sokabe T, Watabe T, Miyazono K, Yamashita JK, Obi S, et al. Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. Am J Physiol Heart Circ Physiol 2005; 288: H1915-H1924.
33. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.